Available courses

Moodle Assessment and Feedback Test 02

Admin

Quiz Test 2

quiz test 2

test course

scorm test

scorm cloud test cloud host

z1234

scorm cloud test werfen host

Software overview of Bio-Flash

Inova

電子署名機能

Werfen

LATAM Distribution Test

LATAM Test

Test Course

John Smith

test22

test22

test22

test22

test22

test22

test2

PACE TEST 2021 V1

A

adsFadf

Test

Test Course

Course

Course

Author: Me

testnamecourse

Bill Smith

c1111

Test

Course 1

ASDFASDF

Nick Test Course

Test Course 1

Customer Learning Manager - Introductory Tutorial

Author: Instrumentation Laboratory

aa

Traumatic Brain Injury Associated Coagulopathy: Theory and Practice

Werfen

Tromboelastograma Visión Hematólogo - Noelia Vilalta - H Sant Pau de Barcelona (2018)

Tromboelastograma visão do hematologista - Noelia Vilalta - H Sant Pau de Barcelona (2018)

Cambio de paradigma en el control biológico del tratamiento de la hemofilia - Dra.Teresa Álvarez- HU La Paz de Madrid (2018)

Einführung zur Hämophilie

Werfen

Mudança de paradigma no controlo biológico do tratamento da hemofilia - Dra.Teresa Álvarez- HU La Paz de Madrid (2018)

Testes viscoelásticos no laboratório de Hemostase - Dr. José Mateo - H Sant Pau de Barcelona (2019)

Test viscoelásticos en el laboratório de Hemostasia - Dr. José Mateo - H Sant Pau de Barcelona (2019)

Conceptos de la Tromboelastometría Rotacional (ROTEM) - Dr. Ihosvany Fernández - HU La Paz de Madrid (2019)

Papel de ROTEM en Hemostasia - Hiperfibrinolisis - Dr. Javier Rodríguez Martorell - HU Virgen del Rocio de Sevilla (2019)

Papel do ROTEM na Hemostase - Hemofilia - Dr. Ihosvany Fernández - H U La Paz de Madrid (2019)

Papel de ROTEM en Hemostasia - Hemofilia - Dr. Ihosvany Fernández - H U La Paz de Madrid (2019)

Papel de ROTEM na Hemostase - Hiperfibrinólise - Dr. Javier Rodríguez Martorell - HU Virgen del Rocio de Sevilla (2019)

Algoritmos de diagnóstico de la EVW y la importancia del Collagen Binding - Dra. Teresa Fidalgo - CHU Coimbra (2019)

Terapias no sustitutivas en las hemofilias - Dr. Víctor Jiménez Yuste - HU La Paz de Madrid (2019)

Introducción a la hemofilia

Werfen

Conceitos da Tromboelastometría Rotacional (ROTEM) - Dr. Ihosvany Fernández - HU La Paz de Madrid (2019)

Algoritmos de diagnóstico de la EVW y la importancia del Collagen Binding - Dra. Mónica Pereira - Hospital Santo António de Porto (2019)

Introdução à hemofilia

Werfen

Aktualne problemy w diagnostyce i leczeniu choroby von Willebranda

Alberto Tosetto, MD

Algoritmos de diagnóstico da DVW e a importância do Collagen Binding - Dra. Mónica Pereira - Hospital Santo António de Porto (2019)

Algoritmos de diagnóstico da DVW e a importância do Collagen Binding - Dra. Teresa Fidalgo - CHU Coimbra (2019)

Introduction to Hemophilia

Werfen

Hemostasis and Anticoagulation in Patients with Liver Dysfunction

Armando Tripodi, PhD and Nicolas Intagliata, MD, MS

Thrombosis and Bleeding in Hematological Malignancies

Jeffrey Zwicker, M.D. and Gabriela Cesarman-Maus, M.D., Ph.D.

Management of Patients on Emicizumab

Will Lester, BSc, MBChB, PhD and Sophie Susen, MD, PhD

Thrombosis and Bleeding in Hematological Malignancies

Jeffrey Zwicker, M.D. and Gabriela Cesarman-Maus, M.D., Ph.D.

Management of Patients on Emicizumab

Will Lester, BSc, MBChB, PhD and Sophie Susen, MD, PhD

Current Issues in VWD: Diagnosis and Management

Alberto Tosetto, MD

Use of Novel Drugs in Hemophilia

Nicola Curry, MD and Margaret V. Ragni, MD

Terapias não-substitutivas para a hemofilia - Dr. Víctor Jiménez Yuste - HU La Paz de Madrid (2019)

Traumatic Brain Injury Associated Coagulopathy: Theory and Practice

Jing-fei Dong, MD, PhD and Marc Maegele, MD

Use of Novel Drugs in Hemophilia

Nicola Curry, MD and Margaret V. Ragni, MD

Hemostasis and Anticoagulation in Patients with Liver Dysfunction

Armando Tripodi, PhD and Nicolas Intagliata, MD, MS

Current Issues in VWD: Diagnosis and Management

Author: Alberto Tosetto, MD

Archive_Advances in Hemophilia

Authors: Peter Collins, MD, FRCP, FRCpath ; Gary Gilbert, MD

Current Issues in VWD: Diagnosis and Management

Alberto Tosetto, MD

Optimizing Clinical and Laboratory Diagnosis of von Willebrand Disease (VWD)

Augusto B. Federici, MD

Pre-analytical Issues in Hemostasis Testing in Low-Resource Settings

Evelyn Cortina de la Rosa, BSc and Akbar Dorgalaleh, PhD

Pre-analytical Issues in Hemostasis Testing in Low-Resource Settings

Evelyn Cortina de la Rosa, BSc and Akbar Dorgalaleh, PhD

Pre-analytical Issues in Hemostasis Testing in Low-Resource Settings

Evelyn Cortina de la Rosa, BSc and Akbar Dorgalaleh, PhD

血液凝固検査における検体の品質の臨床的影響と分析前品質保証の自動化の価値

Anne Winkler, MD, MSc

止血検査の分析前の 変数：悪い検体は患者に悪影響を及ぼす

Steve Kitchen, PhD

止血検査における品質認定要件の課題への対応

Sharon Ehrmeyer, PhD, MT(ASCP)

Utilizing Middleware: HemoHub™ Intelligent Data Manager

Lisa Hodson, MLS (ASCP)

Innovation in Hemostasis: Enhancing Lab Efficiency and Patient Management

Thomas L. Ortel, MD, PhD; Kenneth A. Bauer, MD

Meeting CAP Requirements and CLSI Guidelines for Hemostasis Samples with Automation-Ready Analyzers

Holly Wiles, MBA, MLS (ASCP)cm

Case Study: Improving Efficiency and Patient Care with Hemostasis Specialized Automation

Jayton Zachary, MT (ASCP)

Case Study: Improving Efficiency and Patient Care with Hemostasis Specialized Automation

Jayton Zachary, MT (ASCP)

Case Study: Improving Efficiency and Patient Care with Hemostasis Specialized Automation

Jayton Zachary, MT (ASCP)

Clinical Impact of Sample Quality and the Value of Automating Pre-Analytical Quality Assurance in Hemostasis Testing

Author: Anne Winkler, MD, MSc

Pre-analytical Variables in Hemostasis: Bad samples are bad for patients

Author: Steve Kitchen, PhD

Innovation in Hemostasis: Enhancing Lab Efficiency and Patient Management

Thomas L. Ortel, MD, PhD; Kenneth A. Bauer, MD

Clinical Impact of Sample Quality and the Value of Automating Pre-analytical Quality Assurance in Hemostasis Testing

Anne Winkler, MD, MSc

Pre-analytical Variables in Hemostasis: Bad samples are bad for patients

Steve Kitchen, PhD

Meet the Challenges of Quality Accreditation Requirements in Hemostasis Testing

Sharon Ehrmeyer, PhD, MT(ASCP)

Clinical Impact of Sample Quality and the Value of Automating Pre-Analytical Quality Assurance in Hemostasis Testing

Author: Anne Winkler, MD, MSc

Test Italy Course

Enfermedad de Von Willebrand

Autor: Werfen Iberia

Doença de Von Willebrand

COVID-19 and Thrombosis: An Update

Leo Nicolai, MD and Adela Constantinescu-Bercu, PhD

SARS CoV2 Vaccine-Related Thromboembolic Complications

Florian Langer, M.D.

COVID-19 and Thrombosis: An Update

Leo Nicolai, MD and Adela Constantinescu-Bercu, PhD

Gerinnungsaktivierung und COVID-19 - Neue Aspekte zu D-Dimer.

Prof. Dr. Carl-Erik Dempfle

SARS CoV2 Vaccine-Related Thromboembolic Complications

Florian Langer, M.D.

COVID-19 and Thrombosis: A Case-Based Discussion

Geoffrey Barnes, MD, MSc

Coagulation and Conundrums: COVID-19 and Critical Care – Potential Utility of ROTEM® Testing

Daniel Katz, M.D.

COVID-19 and Hemostasis: Laboratory and Clinical Updates

Armando Tripodi, PhD and Benilde Cosmi, MD

Coagulopathy and Thromboembolism in COVID-19 Patients in Special Populations

Jennifer Davila, MD; Fionnuala Ní Áinle, MD, PhD; Moderator: Rezan Abdul-Kadir, MBChB, MD

COVID-19 Hypercoagulability

Ted Warkentin, MD, BSc (Med), FRCPC, FACP, FRCP (Edin)

Thrombosis in the Hospitalized COVID Positive Patient

Tracy Minichiello, MD

Thrombosis, Thromboprophylaxis and Coagulopathy in COVID-19 Infections

Marcel Levi, MD, PhD and Beverley Hunt, MD, OBE

Thrombotic and Hemostatic Issues in Critical Care Units Managing COVID-19

Jerrold H. Levy, MD, FAHA, FCCM and Nicole P. Juffermans, MD, PhD

Shedding light on anti-Xa: it's role in critical care medicine

Dr. Tim Frentzel Radboudumc Nijmegen, Netherlands

An anti-Xa based anticoaluation protocol with APTT in parallel in critical ill patients: the benefit of dual heparin testing

Prof. dr. Christophe Vandenbriele, Royal Brompton & Harefield NHS Hospital, London UK Heart Center, OLV Hospital Aalst, Belgium

Les tests de coagulation en routine, série 3, le tests FG, TT, D-DI

Werfen Benelux, Groupe Marketing Hémostase

Les tests de coagulation en routine, série 2, le test TP

Werfen Benelux, Groupe Marketing Hémostase

Les tests de coagulation en routine, série 1, Généralités & le test aPTT

Werfen Benelux, Groupe Marketing Hémostase

Routine stolling serie 3, FG, TT en D-Dimeer focus

Werfen Benelux, Hemostase Marketing groep

Routine stolling serie 2, PT focus

Werfen Benelux, Hemostase Marketing groep

Routine stolling serie 1, aPTT focus

Werfen Benelux, Hemostase Marketing groep

Remmer bepaling tegen ADAMTS13

Prof. M. Jacquemin, Katholieke Universiteit Leuven, BE

Bepalen van ADAMTS13

Prof. dr. M. de Maat, Erasmus MC, Rotterdam, NL

Détection et titration des anticorps anti-ADAMTS13

Prof. M. Jacquemin, KUL, Leuven, Belgium

Intérêt du dosage de l’ADAMTS13 : actualités en 2021

Prof. F. Mullier, CHU UCL Namur, Yvoir, Belgium

Dosage des AODs/DOAC anti-Xa, la perspective du laboratoire

Dr. MA. van Dievoet, Cliniques Universitaires St-Luc, Bruxelles, Belgium

Utilisation des tests chromogéniques anti-FXa dans le cadre du suivi de l'HNF et des HBPM: principes de base et recommandations

Prof. J. Douxfils, University of Namur, Namur, Belgium

DOACs meten met een anti-Xa activiteit test

Dr. A. Stroobants, Amsterdam UMC, Amsterdam Nederland

Anticoagulatie monitoring bij kritisch zieke patienten

Prof. dr. C. Vandenbriele, UZ Leuven, Belgie

AccuTrak 2.0

AccuTrak 2.0 fr

Charlotte Bouckaert (PhD) Justine Vagenhende

Fundamentos e diagnostico da talassemia

Salvador Orient - Hemostasis Application Specialist Elisa Montagni - Hemostasis Product Manager

Talasemia: fundamentos y diagnóstico

Salvador Orient - Hemostasis Application Specialist Elisa Montagni - Hemostasis Product Manager

Inibidores adquiridos da coagulação

Ana Cristina Oliveira - Hemostasis Clinical Specialist

Inhibidores adquiridos de la coagulación

Ana Cristina Oliveira - Hemostasis Clinical Specialist

Introduction to ROTEM-Guided PBM

Presented by Maggie Harrington, Clinical Applications Specialist at the 2023 Werfen UGM

Werfen UGM 2023 Presentations- Part 2

Presentations by Grace Gilmore from Perth Blood Institute at Murdoch University and Michael Parker from Monash Health

Werfen UGM 2023 Presentations- Part 1

Presentations by Dr Emmanuel J Favaloro PhD FFSc (RCPA) from ICPMR, NSW Health Pathology and Jeannine Lewis from ACT Pathology, Canberra

Capacitación GenExpert

Werfen en México

Fundamentos de Trombose e Hemostase

Daniel Witt, PharmD, FCCP, BCPS

Innovación de la Biología Molecular aplicada Hemostasia NGS - Dr. Javier Corral - HGU Morales Meseguer de Murcia (2018)

Fundamentos de Hemostasia y Trombosis

Daniel Witt, PharmD, FCCP, BCPS

Inovação da Biología Molecular aplicada à Hemostase NGS - Dr. Javier Corral - HGU Morales Meseguer de Murcia (2018)

Introducción a la Hemostasia

Werfen

Introdução à hemóstase

Werfen

Platelets and Fibrin(ogen) in Progression of Organ Injury and Regeneration

Alice Assinger, PhD and Joris Roelofs, MD, PhD

Hemostasis in ECMO with Pediatric Patients

Paul Monagle, MBBS, MD, MSc, FRACP, FRCPA, FCCP and Heidi Dalton, MD, MCCM, FELSO

Platelets and Fibrin(ogen) in Progression of Organ Injury and Regeneration

Alice Assinger, PhD and Joris Roelofs, MD, PhD

Einführung in die Hämostase

Werfen

Hemostasis in ECMO with Pediatric Patients

Paul Monagle, MBBS, MD, MSc, FRACP, FRCPA, FCCP and Heidi Dalton, MD, MCCM, FELSO

Trombocitopenia induzida por heparina

Daniella Marrese

Screening Geral dos testes de Hemostasia

Werfen América Latina

Controle de Qualidade em Hemostasia

Werfen América Latina

Conceitos Básicos de Hemostasia

Werfen América Latina

Variáveis pré-analíticas em Hemostasia

Werfen América Latina

Conceptos Básicos de Hemostasia

Werfen América Latina

Screening General en Hemostasia

Werfen América Latina

Control de Calidad en Hemostasia

Werfen América Latina

Variables Preanalíticas en Hemostasia

Werfen América Latina

Fisiologia da Coagulação

Daniella Marrese - Werfen Brasil

Cuidados pré-analíticos com as amostras de Hemostasia

Daniella Marrese - Werfen Brasil

Coagulograma - interpretação e casos clínicos

Daniella Marrese - Werfen Brasil

Hipercoagulabilidade e Covid-19

Daniella Marrese - Werfen Brasil

Fibrinólise

Daniella Marrese - Werfen Brasil

Determinação dos fatores de coagulação e paralelismo

Daniella Marrese

Diagnóstico de von Willebrand e novos alvos diagnósticos

Daniella Marrese

Trombofilias

Daniella Marrese

Anticoagulante lúpico

Daniella Marrese

Soluzioni organizzative in Emostasi - Domande e Risposte

Hemostasis and Thrombosis Fundamentals

Daniel Witt, PharmD, FCCP, BCPS

Hemostasis and Thrombosis Fundamentals

Daniel Witt, PharmD, FCCP, BCPS

Pathways in Thrombosis and Hemostasis

Alisa S. Wolberg, PhD FAHA; Helen Philippou, PhD; Moderator: Evi Stavrou, MD

Introduction to Hemostasis

Werfen

Pathways in Thrombosis and Hemostasis

Alisa S. Wolberg, PhD FAHA; Helen Philippou, PhD; Moderator: Evi Stavrou, MD

WHW Portugal_1ª sesión: Microangiopatías Trombóticas + Anticoagulantes Orales de Acción Directa (2020)

Dra. Teresa Fidalgo (Centro Hospitalar e Universitário de Coimbra); Dr. Jorge Martinez (Centro Hospitalar e Universitário Cova da Beira, Covilhã)

WHW Portugal_1ª sessão: Microangiopatias Trombóticas + Anticoagulantes Orais de Ação Direta (2020)

Dra. Teresa Fidalgo (Centro Hospitalar e Universitário de Coimbra); Dr. Jorge Martinez (Centro Hospitalar e Universitário Cova da Beira, Covilhã)

Monitoring and Reversal for Factor Xa Inhibitors

Elena Campello, MD, PhD and Silmara Montalvão, PharmD, MSc, PhD  

Anti-Xa Testing for Heparin Monitoring

Deepa J. Arachchillage, MD

Monitoring and Reversal for Factor Xa Inhibitors

Elena Campello, MD, PhD and Silmara Montalvão, PharmD, MSc, PhD  

Anti-Xa Testing for Heparin Monitoring

Deepa J Arachchillage, MD

DOACs and Cancer: Assessing Important Drug-Drug Interactions

Tristan Groves, DipClin Pharm, IP and Tzu-Fei Wang, MD

Anticoagulation in Special Situations

Kelly Rudd, PharmD, FCCP, BCPS, CACP

DOACs and Cancer: Assessing Important Drug-Drug Interactions

Tristan Groves, DipClin Pharm, IP and Tzu-Fei Wang, MD


Actualización manejo ACODs - Dr. Pere Domenech - HU Bellvitge de Hospitalet del Llobregat (2018)

Actualização da gestão dos ACODs - Dr. Pere Domenech - HU Bellvitge de Hospitalet del Llobregat (2018)

Clinical Application of Anticoagulant Drug Pharmacology

Sara R. Vazquez, PharmD, BCPS, CACP

Clínicas de anticoagulación Cova da Beira - Dra. Patricia Amantegui - CH Cova da Beira (2019)

Anticoagulantes Orales de Acción Directa: "State of the art" - Dr. Pere Domènech - HU Bellvitge de Hospitalet del Llobregat (2019)

Anticoagulation in Special Situations

Kelly Rudd, PharmD, FCCP, BCPS, CACP

Introduction to Direct Oral Anticoagulants (DOACs)

Werfen

Clínicas de anticoagulação Cova da Beira - Dra. Patricia Amantegui - CH Cova da Beira (2019)

Peri-Procedural Anticoagulation Management

Scott Kaatz, DO, MSc

Peri-Procedural Anticoagulation Management

Scott Kaatz, DO, MSc

Anticoagulation in the Pediatric Population

Marilyn Blumenstein, MSN, PPCNP-BC, HN-BC; Jennifer Pak, PharmD, CACP; Leslie Raffini, MD, MSCE

Clinical Application of Anticoagulant Drug Pharmacology

Sara R. Vazquez, PharmD, BCPS, CACP

Anticoagulantes Orais de Ação Directa: "State of the art" - Dr. Pere Domènech - HU Bellvitge de Hospitalet del Llobregat (2019)

Anticoagulation in the Pediatric Population

Marilyn Blumenstein, MSN, PPCNP-BC, HN-BC; Jennifer Pak, PharmD, CACP; Leslie Raffini, MD, MSCE

PARMA GTS - Cerca Paziente

Linea Emostasi, Marketing - Werfen Italy

Direct Oral Anticoagulants: Challenges in the Hemostasis Laboratory

Ashley Sanchez, BS, MT, ASCP

Direct Oral Anticoagulants: Challenges in the Hemostasis Laboratory

Ashley Sanchez, BS, MT, ASCP

Current Management of Cancer-Related Thrombosis

Casey O’Connell, MD, FACP; Anna Falanga, MD; Moderator: Kristen Sanfilippo, MD, MPHS

Laboratory Testing for Patients on Direct Oral Anticoagulants

Armando Tripodi, PhD

DOACs and Reversal in High-Risk Situations

Alice Ma, MD, FACP and Deborah M. Siegal, MD, MSc, FRCPC

Laboratory Monitoring of Heparin Therapies: Achieving Greater Efficiencies and Better Outcomes with Anti-Xa Methodology

Anne Winkler, MD, MSc

Treatment of Cancer-Associated Venous Thromboembolism (VTE)

Marc Carrier, MD, MSc; Nathan Clark, PharmD; Ryan Fleming, PharmD; David Garcia, MD; Tzu-Fei Wang, MD, MPHP

Clinical and Economic Value of Anti-Xa Monitoring in Patients Receiving Unfractionated Heparin

Mark X. Triscott, PhD; Michael Laposata, MD, PhD

Current Reversal and Treatment Strategies for DOAC-Related Bleeding

Megan Barra, PharmD, BCPS, BCCCP; Adam Cuker, MD, MS; Scott Kaatz, DO, MSc; Ronni Nemeth, PharmD, CACP, DPLA; Kelly Rudd, PharmD, FCCP, BCPS, CACPP

Antithrombotic Treatment of Patients with Chronic Kidney Disease(CKD)

Jens Lutz, M.D. and Michele Lambert, M.D., MSTR
All courses